Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality

NCT ID: NCT05192824

Last Updated: 2022-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-10

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was aimed to evaluate the effects of different Orthokeratology,including the size of central optical zone and the height of peripheral reverse curve, on myopia control and visual quality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was aimed to evaluate the effects of different Orthokeratology on myopia control and visual quality. The different optical zone of Orthokeratology lens was divided into 4 groups, ranged from 5.5 mm to 6 mm. And the control group subjects with the single glasses was included. The effectiveness of Orthokeratology was measured by axial length progression. The visual quality of subjects was evaluated by a questionnaire, contrast sensitivity and wavefront aberration.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopic Progression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single-vision glasses

Subjects wearing single-vision glasses CR-39

Group Type NO_INTERVENTION

No interventions assigned to this group

Orthokeratology lenses group 1

Subjects wearing orthokeratology lenses of 5mm optical zone.

Group Type EXPERIMENTAL

Orthokeratology lens

Intervention Type DEVICE

The intervention was according to the design of different optical zone and peripheral reverse curve

Orthokeratology lenses group 2

Subjects wearing orthokeratology lenses of 5.5mm optical zone.

Group Type EXPERIMENTAL

Orthokeratology lens

Intervention Type DEVICE

The intervention was according to the design of different optical zone and peripheral reverse curve

Orthokeratology lenses group 3

Subjects wearing orthokeratology lenses of 6mm optical zone.

Group Type EXPERIMENTAL

Orthokeratology lens

Intervention Type DEVICE

The intervention was according to the design of different optical zone and peripheral reverse curve

Orthokeratology lenses group 4

Subjects wearing orthokeratology lenses of 6mm optical zone and the increased height of peripheral reverse curve.

Group Type EXPERIMENTAL

Orthokeratology lens

Intervention Type DEVICE

The intervention was according to the design of different optical zone and peripheral reverse curve

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Orthokeratology lens

The intervention was according to the design of different optical zone and peripheral reverse curve

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ortho-K

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Myopia: between -1.00D and 4.00D in both eyes
* Astigmatism: \<1.5D for with-the-rule astigmatism, \<1.00D for the against-the-rule astigmatism
* Visual acuity: the best corrected vision acuity(BCVA)≥20/20 in both eyes
* Subjects that volunteer to participate in the clinical trial and sign informed consent

Exclusion Criteria

* Contraindications of wearing Ortho-K.
* Diagnosis of strabismus, amblyopia and other refractive development of the eye or systemic diseases.
* Any type of strabismus or amblyopia
* Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome)
* Ocular conditions which might affect the refractive error (for example, cataract, ptosis)
Minimum Eligible Age

8 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tianjin Eye Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shuxian zhang

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tianjin Eye Hospital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shuxian Zhang, MD

Role: CONTACT

+8618630996574

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shuxian Zhang

Role: primary

+8618630996574

References

Explore related publications, articles, or registry entries linked to this study.

He M, Du Y, Liu Q, Ren C, Liu J, Wang Q, Li L, Yu J. Effects of orthokeratology on the progression of low to moderate myopia in Chinese children. BMC Ophthalmol. 2016 Jul 27;16:126. doi: 10.1186/s12886-016-0302-5.

Reference Type BACKGROUND
PMID: 27464993 (View on PubMed)

Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, Saw SM, Chen H, Bao F, Zhao Y, Hu L, Li X, Gao R, Lu W, Du Y, Jinag Z, Yu A, Lian H, Jiang Q, Yu Y, Qu J. Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis. Ophthalmology. 2016 Apr;123(4):697-708. doi: 10.1016/j.ophtha.2015.11.010. Epub 2016 Jan 27.

Reference Type BACKGROUND
PMID: 26826749 (View on PubMed)

Hu Y, Wen C, Li Z, Zhao W, Ding X, Yang X. Areal summed corneal power shift is an important determinant for axial length elongation in myopic children treated with overnight orthokeratology. Br J Ophthalmol. 2019 Nov;103(11):1571-1575. doi: 10.1136/bjophthalmol-2018-312933. Epub 2019 Jan 31.

Reference Type BACKGROUND
PMID: 30705043 (View on PubMed)

Paune J, Fonts S, Rodriguez L, Queiros A. The Role of Back Optic Zone Diameter in Myopia Control with Orthokeratology Lenses. J Clin Med. 2021 Jan 18;10(2):336. doi: 10.3390/jcm10020336.

Reference Type BACKGROUND
PMID: 33477514 (View on PubMed)

Gifford P, Tran M, Priestley C, Maseedupally V, Kang P. Reducing treatment zone diameter in orthokeratology and its effect on peripheral ocular refraction. Cont Lens Anterior Eye. 2020 Feb;43(1):54-59. doi: 10.1016/j.clae.2019.11.006. Epub 2019 Nov 24.

Reference Type BACKGROUND
PMID: 31776061 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TianjinEH-Orthokeratology lens

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.